UWorld Mental Health Practice Test

Benzodiazepines primarily function by enhancing the effects of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. They bind to specific sites on the GABA-A receptor, increasing the frequency of chloride channel openings. This heightened activity leads to increased neuronal inhibition, resulting in anxiolytic (anxiety-reducing), sedative, muscle relaxant, and anticonvulsant effects. The enhancement of GABA's actions not only alleviates anxiety symptoms but also stabilizes mood and induces relaxation.

In contrast, other mechanisms like inhibition of dopamine transmission, activation of serotonin receptors, and blockade of norepinephrine reuptake do not align with how benzodiazepines operate. Inhibition of dopamine transmission is more characteristic of antipsychotic medications, while serotonin receptor activation is primarily associated with selective serotonin reuptake inhibitors (SSRIs). The blockade of norepinephrine reuptake is related to certain antidepressants, specifically norepinephrine reuptake inhibitors (NRIs). These differences underscore the specific role of GABA potentiation in the therapeutic effects of benzodiazepines in managing anxiety disorders.